<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02694601</url>
  </required_header>
  <id_info>
    <org_study_id>2014-441</org_study_id>
    <nct_id>NCT02694601</nct_id>
  </id_info>
  <brief_title>Ketone Production and Caffeine</brief_title>
  <official_title>Stimulate the Ketogenesis by Using a Caffeine Supplement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the effect of a caffeine supplement on the stimulation of
      lipolysis and the production of ketones in healthy adults (N=10). Two different doses of
      caffeine (2.5 mg/kg of BW and 5 mg/kg of BW) are compared. All the participants have to
      follow three sequential visits of four hours each, which included a breakfast with one of the
      doses (2.5 or 5 mg/kg) of the caffeine supplement or without any supplement (baseline) and
      repeated blood sampling in order to evaluate ketone concentrations.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma acetoacetate concentrations</measure>
    <time_frame>4 hours</time_frame>
    <description>Acetoacetate (uM)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma beta-hydroxybutyrate concentrations</measure>
    <time_frame>4 hours</time_frame>
    <description>Beta-hydroxybutyrate (uM)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose concentrations</measure>
    <time_frame>4 hours</time_frame>
    <description>Glucose (mM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma cholesterol concentrations</measure>
    <time_frame>4 hours</time_frame>
    <description>Total cholesterol (mM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma triglyceride concentrations</measure>
    <time_frame>4 hours</time_frame>
    <description>Triglycerides (mM)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy Adults</condition>
  <arm_group>
    <arm_group_label>Healthy adults</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>For each 4-hour visit, a dose of 0 mg/kg, 2.5 mg/kg or 5 mg/kg of Caffeine is given during a standardize breakfast follow by repeated blood sampling.</description>
    <arm_group_label>Healthy adults</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults

          -  18 years old and over

        Exclusion Criteria:

          -  Drinking more than 300 mg of caffeine per day

          -  Diabetes or prediabetes

          -  Abnormal liver and kidney function

          -  Uncontrolled dyslipidemia, blood pressure

          -  Use of drugs known to influence the metabolism of lipids and carbohydrates (steroid,
             beta-blockers, diuretics, insulin sensitizer, etc.)

          -  Severe inflammation or infection

          -  Pregnancy

          -  Smoking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Cunnane, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Centre on Aging - CSSS-IUGS - CIUSSS de l'Estrie - CHUS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS)</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H4C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2016</study_first_submitted>
  <study_first_submitted_qc>February 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2016</study_first_posted>
  <last_update_submitted>February 23, 2016</last_update_submitted>
  <last_update_submitted_qc>February 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>September 12, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

